martes, 5 de febrero de 2019

Concerned about Gawande’s new venture, Optum sues over trade secrets

Concerned about Gawande’s new venture, Optum sues over trade secrets

STAT
Each month, STAT Plus aims to bring our readers market-moving analysis of the biotech, pharma, and life sciences industries. Our team of veteran reporters — from Sharon Begley to Matthew Herper — help cut through the noise to bring you the most impactful headlines, and analysis of the people, policies, and scientific breakthroughs making waves in the industry.

In a sign of its concerns about Atul Gawande’s new venture, Optum sues over trade secrets

No hay comentarios: